| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |